Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
Although activated Notch receptors have been associated with chemoresistance in cancer, the role of specific Notch ligands remain elusive. Here, the authors show that in breast cells the Notch ligand DLL1 is expressed in cells with a cancer stem cell phenotype and promote doxorubicin resistance in p...
Enregistré dans:
Auteurs principaux: | Sushil Kumar, Ajeya Nandi, Snahlata Singh, Rohan Regulapati, Ning Li, John W. Tobias, Christian W. Siebel, Mario Andres Blanco, Andres J. Klein-Szanto, Christopher Lengner, Alana L. Welm, Yibin Kang, Rumela Chakrabarti |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a82e2a88c87b4da18c5103c84eb99f0b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The role of DLL1 in long-term vascular normalization and cancer immunotherapy
par: Qiaozhen Wu, et autres
Publié: (2021) -
Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis
par: Nan W. Hultgren, et autres
Publié: (2020) -
Maintenance of quiescent oocytes by noradrenergic signals
par: Jeongho Kim, et autres
Publié: (2021) -
Feedback regulation of Notch signaling and myogenesis connected by MyoD-Dll1 axis.
par: Haifeng Zhang, et autres
Publié: (2021) -
Peripheral monocyte functions and activation in patients with quiescent Crohn's disease.
par: David Schwarzmaier, et autres
Publié: (2013)